Development and optimization of Clitoria teratea synthesized silver nanoparticles and its application to nanogel systems for wound healing
OBJECTIVE: The present research deals with sequential optimization strategy based on Central Composite Design to optimize the process variables for efficient production of Clitoria teratea (CLT) synthesized silver nanoparticles (AgNPs) using biological synthesis.
METHODS: Two substantial factors influencing the dependent variables viz UV-visible absorbance, particle size, zeta potential and polydispersity index (PDI) were identified as NaOH concentration, RH concentration, temperature as independent variables. In-vitro and ex-vivo studies of prepared CLT-AgNPs gel and marketed gel were carried out using dialysis membrane and egg membrane, respectively. In addition, antimicrobial study was also performed on the bacterial strains.
RESULTS: The particles size (114 nm), PDI (0.45), and zeta potential (-29.5 mV) of optimized formulation were found, respectively. In-vitro profile of AgNPs from prepared CLT-AgNPs gel was noted (95.6%) in 8 h. It was found that the prepared CLT-AgNPs gel stimulates fibroblast and agranulocytosis development resulting better and timely wound healing.
CONCLUSIONS: The prepared CLT-AgNPs gel can be as a potential substitute in the management and treatment of acute and chronic wounds.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Drug development and industrial pharmacy - 50(2024), 3 vom: 06. März, Seite 181-191 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jain, Richa [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.03.2024 Date Revised 21.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/03639045.2024.2308043 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368079406 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368079406 | ||
003 | DE-627 | ||
005 | 20240322000014.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240206s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/03639045.2024.2308043 |2 doi | |
028 | 5 | 2 | |a pubmed24n1338.xml |
035 | |a (DE-627)NLM368079406 | ||
035 | |a (NLM)38318676 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jain, Richa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development and optimization of Clitoria teratea synthesized silver nanoparticles and its application to nanogel systems for wound healing |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.03.2024 | ||
500 | |a Date Revised 21.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The present research deals with sequential optimization strategy based on Central Composite Design to optimize the process variables for efficient production of Clitoria teratea (CLT) synthesized silver nanoparticles (AgNPs) using biological synthesis | ||
520 | |a METHODS: Two substantial factors influencing the dependent variables viz UV-visible absorbance, particle size, zeta potential and polydispersity index (PDI) were identified as NaOH concentration, RH concentration, temperature as independent variables. In-vitro and ex-vivo studies of prepared CLT-AgNPs gel and marketed gel were carried out using dialysis membrane and egg membrane, respectively. In addition, antimicrobial study was also performed on the bacterial strains | ||
520 | |a RESULTS: The particles size (114 nm), PDI (0.45), and zeta potential (-29.5 mV) of optimized formulation were found, respectively. In-vitro profile of AgNPs from prepared CLT-AgNPs gel was noted (95.6%) in 8 h. It was found that the prepared CLT-AgNPs gel stimulates fibroblast and agranulocytosis development resulting better and timely wound healing | ||
520 | |a CONCLUSIONS: The prepared CLT-AgNPs gel can be as a potential substitute in the management and treatment of acute and chronic wounds | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Clitoria teratea | |
650 | 4 | |a HET-CAM assay | |
650 | 4 | |a Silver nanoparticles | |
650 | 4 | |a chromac assay | |
650 | 4 | |a egg membrane | |
650 | 7 | |a Silver |2 NLM | |
650 | 7 | |a 3M4G523W1G |2 NLM | |
650 | 7 | |a polyethylene glycol polyethyleneimine nanogel |2 NLM | |
650 | 7 | |a Nanogels |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Polyethylene Glycols |2 NLM | |
650 | 7 | |a 3WJQ0SDW1A |2 NLM | |
650 | 7 | |a Polyethyleneimine |2 NLM | |
650 | 7 | |a 9002-98-6 |2 NLM | |
700 | 1 | |a Singh, Ruchi |e verfasserin |4 aut | |
700 | 1 | |a Badhwar, Reena |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Tinku |e verfasserin |4 aut | |
700 | 1 | |a Popli, Harvinder |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug development and industrial pharmacy |d 1994 |g 50(2024), 3 vom: 06. März, Seite 181-191 |w (DE-627)NLM077783093 |x 1520-5762 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2024 |g number:3 |g day:06 |g month:03 |g pages:181-191 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/03639045.2024.2308043 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2024 |e 3 |b 06 |c 03 |h 181-191 |